Investor Overview

Satsuma Pharmaceuticals Investor Relations

 

Recent News
May 11, 2021

South San Francisco, CA, May 11, 2021 – Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a clinical-stage biopharmaceutical company developing STS101, a novel therapeutic product candidate for the...

Mar 25, 2021

South San Francisco, CA, March 25, 2021 – Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a clinical-stage biopharmaceutical company developing STS101, a novel therapeutic product candidate for...

Mar 10, 2021

March 10, 2021 South San Francisco, CA, March 10, 2021 – Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA) a clinical-stage biopharmaceutical company, today announced that management will present a...

Stock Info
NASDAQSTSA